Advanced Prostate Cancer Clinical Trials

46 clinical trials for Advanced Prostate Cancer across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer — RECRUITING · PHASE1
• A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer — RECRUITING · PHASE1
• PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer. — RECRUITING · PHASE1
• A Clinical Study of QLC5508 and/or QLH12016 in Combination With Other Anti-tumor Therapies in Subjects With Advanced Prostate Cancer — RECRUITING · PHASE1
• A Phase 1 Study of JNJ-87189401 Combined with JNJ-78278343 for Advanced Prostate Cancer — RECRUITING · PHASE1
• Lab Research Using Mini-tumors to Study Prostate Cancer Treatments — RECRUITING
• Engage Psychosocial Intervention for Cancer Symptoms — RECRUITING · NA
• Dual PSMA and FDG PET Imaging for Patients With Advanced Prostate Cancer — RECRUITING · NA
• Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer — RECRUITING · PHASE1
• Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT — RECRUITING · PHASE1
• HS-10502 Combination Treatment in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• Whole Body MRI in Oncology — RECRUITING
• European Registry of Next Generation Imaging in Advanced Prostate Cancer — RECRUITING
• Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) — RECRUITING · PHASE1
• Phase II, randomized, multicentric study of docetaxel and zoledronic acid versus zoledronic acid in patient with prostate cancer and bone metastase treated with LHRH — TERMINATED · PHASE2
• Efficacy and Safety of DKF-MA102 in Patients With Prostate Cancer — COMPLETED · PHASE3
• Study of XNW5004 Tablets in Advanced Prostate Cancer — NOT_YET_RECRUITING · PHASE2
• A Phase 2, Open-Label, Single-Arm, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients with Advanced Prostate Cancer — NOT_YET_RECRUITING · PHASE2
• A Phase 2, randomized, open-label, dose-finding study of Debio 4228, an extended-release formulation of gonadotropin-releasing hormone antagonist in participants with advanced prostate cancer — OTHER · PHASE2
• DEC003M in Prostate Cancer — NOT_YET_RECRUITING · PHASE1
• Study of PSMA-targeted Therapy and Androgen Receptor Suppression in Low-volume Metastatic ProstatE Cancer: SPARKLE Trial — NOT_YET_RECRUITING · PHASE2
• A Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix DP, a Gonadotropin-releasing Hormone (GnRH) Antagonist, in Patients With Advanced Prostate Cancer — NOT_YET_RECRUITING · PHASE2
• Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) — ACTIVE_NOT_RECRUITING · PHASE2
• SRAM study_Postate Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate — COMPLETED · PHASE3
• The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. — COMPLETED · PHASE3
• Goserelin 10.8mg Injection in Treatment of Advanced Prostate Cancer — COMPLETED · PHASE3
• Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer — COMPLETED · PHASE1
• Study of HPN424 in Patients With Advanced Prostate Cancer — TERMINATED · PHASE1
• Nivolumab With or Without Ipilimumab in Advanced Metastatic Cancer — COMPLETED · PHASE2
• Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer — OTHER · PHASE1
• A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy. — TERMINATED · PHASE4
• Whole Body Magnetic Resonance Imaging Study — OTHER
• PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel. — OTHER
• PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide. — OTHER
• PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate. — OTHER
• PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223. — OTHER
• Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. — COMPLETED
• A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer — COMPLETED
• A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer — COMPLETED
• TUPKRP Combined With MAB Therapy for LUTS/PCa — OTHER · NA
• Cabazitaxel and BKM120 in Patients With Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Previously Treated With Docetaxel — WITHDRAWN · PHASE2
• Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) — COMPLETED
• Prostate Cancer, Androgen Deprivation Withdrawal and Intermittent Chemotherapy — OTHER · PHASE3
• Evaluation of Prostate-Specific Antigen (PSA) Levels in Patients With Advanced Prostate Cancer Treated With Bicalutamide — COMPLETED

Refine this search